superb point awss, as usual and unfortunately, the kiddies get screwed in business deals like this. But that's what this comes down to, business...I don't know what to say. I hope they don't mind b.i.d. and consume a proper caloric intake before they inject!
The real losers in this deal are the patients. In my opinion ... which will not be very popular ... the best thing that could happen now is for TRCA to acquire INSM. Then TRCA would have the whole enchilada and could make IPLEX available for any and all approved indications.
This would probably be the best for INSM shareholders also.
News 
Market Data 
Discover 
AI
